Months, and maybe even over a year, have gone by since you last breastfed your baby, but your milk continues to leak or flow. Your period hasn't shown up yet, and you're starting to ask questions.

This prolonged lactation without breastfeeding, known as galactorrhea, when combined with the absence of regular menstrual periods (amenorrhoea) and ovulation (anovulation) points to a rare hormonal condition called Chiari-Frommel Syndrome (CFS).^1,2

What is Chiari-Frommel Syndrome?

Chiari-Frommel Syndrome (CFS), also called Galactorrhea-Amenorrhea Syndrome, is an uncommon endocrine disorder that affects women, usually between the ages of 17 and 35, who have recently given birth (postpartum women).^1,2 It affects a small fraction of women and may even resolve on its own without treatment.²

The major symptoms of this disorder are:

• Galactorrhea - When your breast produces milk on its own in the absence of breastfeeding
• Anovulation - Absence of ovulation
• Amenorrhea - Missing your menstrual periods

These symptoms occur for an abnormally long period of time, often more than six months after breastfeeding has stopped.

Other manifestations include:^1,2

• Puerperal uterine and ovarian atrophy - Reduction in size and function of the ovary and uterus
• Headache
• Abdominal pain
• Visual impairment 
• Hyperprolactinemia - High prolactin level
• Hypoestrogenism - Low oestrogen level 
• Hirsuties 
• Anxiety 
• Occasionally obesity 

Persistent galactorrhea in the absence of breastfeeding, especially when accompanied by the above symptoms, should be investigated as it might indicate CFS.⁵

Normal lactation physiology

Lactation (Breastfeeding) is controlled by a balance of hormones involving the hypothalamic–pituitary axis.

Prolactin is secreted by the anterior pituitary gland. It is the main hormone that promotes the growth of breast tissue and the production of milk. During pregnancy, prolactin levels naturally increase. They peak after the baby is delivered and remain high while nursing.Because of its positive feedback mechanism, stimulation of the nipple through sucking further triggers the release of prolactin, allowing more milk to be produced.^6,7

Oxytocin is released by the posterior pituitary gland and produced by the hypothalamus. It triggers the “let-down reflex” (flow of milk) by stimulating contraction of myoepithelial cells around the milk ducts, allowing milk to be expelled from the breast.^7,8 

Dopamine, a prolactin-inhibiting factor, from the hypothalamus inhibits prolactin secretion under normal circumstances. This inhibition is reduced during breastfeeding to allow milk production, but in disorders like CFS, the suppression of dopamine activity can last longer, leading to persistent hyperprolactinemia and lactation even without infant demand.⁹ 

Cessation of lactation 

Once breastfeeding stops, prolactin levels drop significantly. If no suckling occurs, prolactin returns to non-pregnant levels within 1-2 weeks, leading to the gradual involution of the mammary glands (breast tissue returning to its pre-pregnancy state) and the end of lactation.¹¹

Additionally, a lack of milk removal triggers a negative feedback mechanism that inhibits lactation, further reducing milk synthesis and promoting the involution of breast tissue.

Pathophysiology: What Goes Wrong in Chiari-Frommel Syndrome (CFS)

In CFS, the normal hormonal shutdown mechanisms after weaning are disrupted:

Dopamine-mediated inhibition fails: Under typical conditions, dopamine suppresses the release of prolactin from the pituitary. In CFS, this inhibitory pathway is impaired, either due to hypothalamic dysfunction or subtle pituitary abnormalities, resulting in persistent hyperprolactinemia despite the absence of breastfeeding stimulus.^3,9

Persistent high prolactin levels inhibits gonadotropin-releasing hormone (GnRH): Elevated prolactin leads to suppressed GnRH from the hypothalamus, which in turn reduces LH and FSH release from the pituitary, resulting in amenorrhea, anovulation, and hypoestrogenism (low oestrogen levels) characteristic of CFS.^3,12

Continuous hyperprolactinemia drives galactorrhea (continued milk secretion) and contributes to uterine and ovarian atrophy due to the prolonged absence of estrogen and progesterone cycles.^2,12

Possible causes 

1. Prolactin-Secreting Pituitary Microadenomas (Prolactinomas): Small adenomas can independently increase prolactin production and are a common cause of symptomatic hyperprolactinemia^13,14
2. Hypothalamic or Pituitary-Stalk Lesions: Tumours or structural disruptions (e.g., craniopharyngioma, stalk compression) can block dopaminergic inhibition of prolactin, leading to increased prolactin levels even in the absence of adenomas¹³
3. Idiopathic Hyperprolactinemia: When thorough testing (including magnetic resonance imaging (MRI)) fails to reveal an underlying lesion, the hyperprolactinemia is considered idiopathic (cause is unknown). This may be due to very small adenomas or hypothalamic dopamine defects that could not be detected on imaging^1,13

Diagnostic Approach

History

Doctors start with a thorough patient history that will guide the diagnostic pathway:

• Obstetric and breastfeeding history: Ask about the timing since delivery and duration of breastfeeding to understand the baseline postpartum state
• Menstrual cycle pattern: Track the return, regularity, or absence of menses to assess reproductive axis involvement
• Fertility history: Document attempts at conception or any reproductive planning. This helps highlight functional reproductive suppression
• Associated symptoms: Ask about headaches, visual disturbances, or weight changes, as these may hint at pituitary mass effect or broader endocrinopathy (e.g., prolactinoma)^15,18

Physical examination

The exams should focus on detecting both hormonal and neurological signs:

• Breast exam: Check for spontaneous or expressible milk to confirm galactorrhea
• Neurological assessment: Evaluate cranial nerves and visual fields (e.g., confrontational test) in case of optic chiasm compression from a pituitary lesion¹⁶ 
• Endocrine clues: Search for signs, such as hypothyroidism or clinical features of Cushing's Syndrome, that could mimic or contribute to galactorrhea

Laboratory investigations

A thorough approach to lab tests makes it clear how well the endocrine system is working:

• Serum prolactin: Perform a fasting mid-morning sample to reduce variability. A single markedly elevated result may suffice, while mild elevations warrant repeat tests^12,15,17
• Gonadotropin and estrogen levels (LH, FSH, estradiol): These evaluate how well the hypothalamic-pituitary-gonadal axis functions
• Thyroid function tests: Exclude hypothyroidism as a reversible cause of hyperprolactinemia.¹⁶
• β-hCG: Always rule out pregnancy in patients with amenorrhea
• Renal function tests: Chronic renal impairment can increase prolactin and must be ruled out¹⁶ 

Imaging

If lab tests confirm hyperprolactinemia and no drug or systemic causes are found, imaging is essential:

MRI of the pituitary/hypothalamus: Gold standard to detect adenomas or structural abnormalities. This also helps differentiate prolactinomas from CFS when imaging is normal.^2,15,16 

Key Diagnostic Clues Specific to Chiari-Frommel Syndrome (CFS)

Lactation continues with no baby to feed

When milk production persists long after breastfeeding has ended, it’s a clear signal. In CFS, galactorrhea happens in the complete absence of infant stimulation.^2,3

No other clear cause for high prolactin levels

If pregnancy, medications, thyroid issues, kidney problems, or tumours have been ruled out, yet galactorrhea continues, this unexplained hyperprolactinemia strongly points to CFS.^19,20,21

Pituitary scans are often normal or show minimal changes

In CFS patients, MRI scans typically come back (or nearly so) and do not show large tumours. This helps differentiate CFS from more common prolactin-secreting tumours (prolactinomas).^2,3,15,19

Amenorrhea with suppressed reproductive hormones

Missing periods in CFS,due to low levels of LH and FSH triggered by elevated prolactin levels, are traits of hypogonadotropic hypogonadism.^19,20

These findings (ongoing lactation without clear cause, normal imaging, and a consistent hormonal pattern) form a reliable way to spot CFS and separate it from other causes of galactorrhea and amenorrhea.

Prognosis

Generally favourable with early recognition

CFS often resolves on its own. In many cases, reproductive hormones return to normal and periods resume even without treatment, especially when detected early.^1,3

Restoration of fertility is possible in most cases

With hormonal balance restored, either spontaneously or with medical support, fertility often restores. This makes the outlook hopeful for women who wish to conceive.^1,3

Importance of consistent long-term hormonal follow-up

Even after symptoms fade, keeping an eye on hormone levels is important. Regular follow-up helps catch any recurrence or long-term consequences early, like low estrogen-related bone changes.^22,23

Summary

Chiari-Frommel Syndrome (CFS) is an uncommon but important condition that shows up as prolonged milk production without breastfeeding, missed periods, and a lack of ovulation. Normally, milk supply shuts down once breastfeeding stops because prolactin levels fall and hormone balance returns to normal. In CFS, this “off switch” does not work properly, leaving prolactin levels too high and reproductive hormones too low.

The diagnosis relies on careful history-taking, breast and neurological examination, hormone tests, and pituitary imaging. What makes CFS stand out from other conditions is that milk production continues without any stimulation from a baby, no other cause for high prolactin can be found, pituitary scans are often normal, and reproductive hormones show a suppressed pattern.

The good news is that things look good for the most part. Many women see their cycles and fertility return, either on their own or with medical treatment. Still, long-term follow-up is essential to monitor hormone health and prevent complications.

CFS reminds us that prolonged lactation without demand is not just a nuisance but an important signal from the body that deserves medical attention. With timely recognition, women can protect both their reproductive health and overall well-being.